Deals

Market Rebounds in November; OIS Index Does Not

OIS Index

The OIS Index of ophthalmic stocks declined by 2.3% in November on the heels of a 17.7% decline in October, failing to participate in the market rebound that lifted most stocks following the October sell-off. During November, the overall US stock market as measured by the Russell 3000 Index gained 1.8% following its 7.5% decline…

Read More

OIS@AAO Has a Record Year; So Does Ophthalmology Sector

OIS@AAO Has a Record Year; So Does Ophthalmology Sector

CHICAGO – A record crowd gathered for the 10th anniversary of OIS@AAO last week in Chicago, and one of the highlights is always the Year in Review delivered by OIS chairman Emmett Cunningham Jr., MD, PhD, MPH, who summarized “a banner year – a remarkable year really” for ophthalmology approvals by the Food and Drug…

Read More

OIS Index Follows Stock Market Lower in October

OIS Index

The OIS Index of ophthalmic stocks declined by 17.7% during the October market correction, which saw a 7.5% decline in the overall US stock market as measured by the Russell 3000 Index. Healthcare stocks underperformed in October: the NASDAQ Biotechnology Index lost 14.6% of its value, and a composite of US medical device stocks declined…

Read More

The Sweet Six: Recipients of the 2018 Ophthalmology Innovation Awards

The Sweet Six: Recipients of the 2018 Ophthalmology Innovation Awards

The first Ophthalmology Innovation Awards were presented last night at the OIS-X Gala. Here’s a rundown of the award winners. Clinical Innovator: Ike Ahmed, MD Dr. Ahmed has been a leader in novel treatments for glaucoma, cataract, and lens implant surgery. His pioneering work in innovative glaucoma surgery includes coining the term microinvasive glaucoma surgery…

Read More

The Gems You’ll Find at OIS@AAO 2018

The Gems You’ll Find at OIS@AAO 2018

Diamonds are emerging as the new 10th anniversary gift. Here’s a look at a few of gems you can mine at the 10th OIS@AAO in two Thursdays, on October 25, at the Marriott Marquis in Chicago a day before the American Academy of Ophthalmology (AAO) annual meeting gets underway. Breakfast Breakout Sessions. This year’s seven…

Read More

Small Cap Stocks Lead the Way for OIS Index in September

Small Cap Stocks Lead the Way for OIS Index in September

The OIS Index of ophthalmic stocks gave back some of its recent gains in September, declining by 4.1% against an overall flat market backdrop. The NASDAQ Biotechnology Index and the overall US stock market as measured by the Russell 3000 Index were essentially unchanged during the month, while a composite of US medical device stocks…

Read More

Glaukos and STAAR Drive OIS Index into Record Territory

Glaukos and STAAR Drive OIS Index into Record Territory

The OIS Index of ophthalmic stocks surged to new highs in August, driven by two of the highest-weighted stocks in the index. The OIS Index gained 16.3% in August, while the overall US stock market, as measured by the Russell 3000 Index gained 3.3%, the NASDAQ Biotechnology Index gained 4.8%, and a composite of US…

Read More

OIS Index Lags Market Benchmarks in July

OIS Index

The OIS Index of ophthalmic stocks declined by 1.1% in July, against a strong overall market backdrop. During the month, the overall US stock market as measured by the Russell 3000 Index gained 3.9%, while the NASDAQ Biotechnology Index gained 8.6% and a composite of US medical device stocks gained 4.7%. Within the index, declining…

Read More

OIS Index Hits New Highs; Two New Companies Added

OIS Index

The OIS Index stayed in four-digit territory in June, finishing the month at 1,017 and again outperforming its stock market benchmarks. The OIS Index gained 2.1% during the month, while the NASDAQ Biotechnology Index declined by 0.9%; the overall US stock market, as measured by the Russell 3000 Index, declined by 0.1%; and a composite…

Read More

What’s Next for Alcon Spin-off

What’s Next for Alcon Spin-off

As Novartis unveiled plans to spin off its Alcon eye care unit, the Swiss healthcare giant named Alcon CEO Mike Ball chairman-designate to guide the transformation of the Fort Worth, TX-based unit into a Swiss-based global device company. How much will the spin-off bring in? In the announcement, Novartis also said it would buy back…

Read More

Ophthalmic Stocks’ Rally Rolls Through April

Ophthalmic Stocks' Rally Rolls Through April

The OIS Index gained 5.2% in April, on the heels of a 4.4% gain in March. Ophthalmic stocks have far outperformed key market benchmarks over the past one and three months. The NASDAQ Biotechnology Index declined 3% in April, while the overall US stock market as measured by the Russell 3000 Index gained 0.3% and…

Read More